Rosaceiform dermatitis associated with topical tacrolimus treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20466178.
- Also identified by DOI 10.1016/j.jaad.2009.01.029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe herein 3 patients who developed rosacea-like dermatitis eruptions while using 0.03% or 0.1% tacrolimus ointment for facial dermatitis. Skin biopsy specimens showed telangiectasia and noncaseating epithelioid granulomatous tissue formation in the papillary to mid dermis. Continuous topical use of immunomodulators such as tacrolimus or pimecrolimus should be regarded as a potential cause of rosaceiform dermatitis, although many cases have not been reported.
Medical subject headings
- Facial Dermatoses
- Immunosuppressive Agents
- Rosacea
- Tacrolimus